Impact of Pre-Transplant Molecular Measurable Residual Disease (MMRD) and European Leukemianet (ELN) Genetic Classification in Clinical Outcomes for Acute Myeloid Leukemia (AML) Patients (pts) Undergoing Allogeneic Stem Cell Transplantation (Allohct)
Transplantation and cellular therapy(2021)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要